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Abstract: 
 
Background: Past research has shown discrepancies between the time of symptom onset for 
patients with acute coronary syndrome (ACS) as documented in the medical record (MR) and 
patients’ recall of the time assessed through subject interviews done later by researchers. 
 
Purpose: The aim of this study is to determine if there were differences between the time of 
symptom onset documented in the MR and subject interview taking into consideration sex, age 
group, and recall period for patients admitted to the emergency department for symptoms 
suggestive of ACS. 
 
Methods: A secondary analysis was conducted on data from the PROMOTION (Patient 
Response to Myocardial Infarction Following a Teaching Intervention Offered by Nurses) trial, a 
multicenter randomized clinical trial to reduce patient prehospital delay to treatment in ACS. 
 
Results: Of the 3522 subjects with CAD enrolled into the trial, 3087 subjects completed 2-year 
follow-up. Of these, 331 subjects sought treatment in the emergency department for ACS 
symptoms and 276 patients (83%) had complete information on the time of symptom onset from 
both sources. Of the 276 patients, 25 (9%) had differing times more than 48 hours and were thus 
excluded. The median difference between the 2 sources was 45.0 minutes. When both times were 
examined, there were no significant differences in time by sex (P = .720) or by age group (P = 
.188). The median number of days between the interview and the date of symptom onset was 
29.5 days. There was a significant correlation between differences in the time of symptom onset 
and the length of recall period (rs = 0.148, P = .023). In multivariable modeling, a longer recall 
period was associated with greater median differences in the symptom onset time (b = 13.2, P = 
.023). 
 
Conclusion: These results suggest that the time of symptom onset obtained at the time of the 
index event and documented in the MR is not interchangeable with data obtained later by 
research staff, especially if the interview is not conducted near the time of the index event. 
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Article: 
 
The time of symptom onset for patients with acute coronary syndrome (ACS) is frequently used 
to calculate total ischemic time, defined as the time of symptom onset to the time of the first 
coronary artery balloon inflation.1 Total ischemic time could be influenced by patient-related 
delays, such as when patients fail to recognize and act upon symptoms of ACS, or hospital-
related delays, such as when clinicians fail to diagnose patients in a timely manner once they 
enter the health care system. Either type of delay influences whether patients with ACS are 
eligible for acute reperfusion therapy. The longer the total ischemic time, the larger the infarction 
and the worse the patient outcomes are. For example, total ischemic time has been shown to 
correlate better with infarct size and mortality compared with the door-to-balloon time interval in 
patients with ACS.1 
 
Total ischemic time has been identified as 1 criterion of quality care for patients with ACS. Thus, 
accuracy in collecting and documenting this time interval by clinicians to maximize patient 
outcomes and demonstrate quality care is important. The time of the first coronary balloon 
inflation is relatively easy to define and obtain from the medical record (MR). However, a 
challenge remains in how consistent hospitals across the country operationally define the time of 
symptom onset with patients with symptoms of ACS. In fact, the American College of 
Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards 
advocates a consistent definition for the time of symptom onset as the time when the patient first 
notes ischemic symptoms lasting 10 minutes or longer.2 
 
In addition, cardiovascular researchers who investigate prehospital delay in patients with ACS 
frequently use the time of symptom onset to calculate prehospital delay time as an outcome 
variable for their research. When designing their studies, researchers have to decide whether to 
obtain these data from the MR, to interview subjects themselves, or to combine the 2 sources to 
obtain more complete data. Each source has the potential for measurement error. 
 
Some researchers consider the MR to be the ‘‘gold standard’’ because these data are collected 
and documented in ‘‘real time’’ and thus are less subject to recall bias. However, the MR is 
designed for clinical use, and data obtained fromt his source may be limited by legibility, 
completeness, and accessibility. Past studies have shown that the percentage of missing or 
incomplete symptom onset data in the MR for patients with acute myocardial infarction ranged 
from 14%to 40%.3-7 Furthermore, patients who are older and are female are more likely to have 
missing or incomplete time of symptom onset data in the MR.3 
 
Other researchers prefer interviewing subjects firsthand to obtain the time of symptom onset, 
either in-person or by telephone, after the index event. However, subject interviews done late in 
the course of care can be challenging. For example, subjects need to be willing, able, and 
available to participate. In addition, data collected by subject interviews done after the ACS 
event may also be lacking in completeness. For example, 2 studies reported the percentage of 
missing or incomplete data regarding the time of symptom onset from subject interviews ranged 
from 12% to 13%.6,7 Furthermore, using a combination of the 2 data sources is costly and 
resource intensive. 
 
The question then is whether these data sources are interchangeable. Four studies conducted over 
a decade reported sizeable disagreements between the symptom onset time assessed during the 
index event as documented in the MR and the symptom onset time obtained by interview later 
after the event.4-7 However, 2 of those studies were limited to patients with acute myocardial 
infarction and did not include patients with unstable angina (part of the full ACS spectrum).6,7 In 
addition, there have been a few changes in the past decade that warrant further investigation of 
these issues. For example, recently, there has been increased emphasis on assessing symptoms 
more broadly for atypical presentations (symptoms other than chest pain or pressure such as 
shortness of breath, diaphoresis, nausea, and pain or discomfort in the jaw, neck, back, arm, or 
upper abdomen). National initiatives from the American Heart Association such as Go Red 
forWomen,8,9 which includes atypical symptom presentations in women, have broadened 
interview techniques by clinicians who assess patients in the acute setting. Also, outcomes-based 
quality improvement initiatives such as the American College of Cardiology/American Heart 
Association Acute Coronary Treatment and Intervention Outcomes Network Registry/ Get with 
the Guidelines10 program now track total ischemic time in relation to patient outcomes as a 
measure of quality of care in patients with ACS. Individual hospital reports for these initiatives 
include the percentage of missing data on issues such as the time of symptom onset, thereby 
providing hospitals an opportunity to implement corrective measures to improve data collection 
and documentation. Given these new developments, the study reported here was designed to 
determine if there were currently differences between the times of symptom onset in the MR and 
subject interview, taking into consideration sex, age group, and recall period based on the date of 
the interview with patients admitted to the emergency department (ED) for symptoms suggestive 
of ACS. 
 
METHODS 
 
This secondary analysis was conducted on data from the PROMOTION (Patient Response to 
Myocardial Infarction Following a Teaching Intervention Offered by Nurses) trial. The 
PROMOTION trial,11 a randomized clinical trial, tested a face-to-face intervention designed to 
reduce patient delay in seeking treatment for ACS symptoms. Patients with a history of cardiac 
disease were enrolled, randomized to usual care or intervention and then followed for 2 years for 
occurrence of ACS symptoms. Patients were instructed to call the investigators (after the acute 
event was over) when they sought treatment for symptoms they believed were cardiac in origin. 
In the event that patients did not contact the investigators after an ED visit, patients were also 
telephoned every 6 months by investigators to discuss whether there had been any unreported ED 
visits for ACS. Patients who sought treatment for symptoms for presumed ACS were interviewed 
using techniques that the investigators had developed to assist patients most closely determine 
the time of symptoms onset. 
 
SAMPLE 
 
Of the 3522 patients with a history of CAD who were enrolled in the PROMOTION study, 3087 
(88%) completed 2-year follow-up.11 Of these, 565 had ED admissions with symptoms 
suggestive of ACS.12 Of the 565 patients, 331 (59%) were diagnosed with ACS (and these were 
included in the current study).12 Among these 331 patients, 11 (3%) were missing time of 
symptom onset in the MR and 48 (15%) were missing the time of symptom onset from subject 
interviews; thus, 55 patients (17%) were missing data from either MR or subject interview. 
 
A total of 276 patients (83%) had complete data from both sources. Of these patients, for 25 
(9%), there was a difference of more than 48 hours in time of symptom onset reported in the MR 
and the interview. Because this difference was so large, these patients were not included in the 
analysis. The remaining sample of 251 ACS patients is the focus of this report. 
 
DATA ANALYSIS 
 
Patient sample characteristics were assessed using descriptive statistics. Differences in time of 
symptom onset between the MR and interview were calculated in minutes and were categorized 
as less than 30 minutes, 30 to less than 60 minutes, 60 to less than 90 minutes, and 90 minutes to 
48 hours. Age at enrollment in the study was categorized as 65 years or younger, 66 to 79 years, 
and 80 years or older. Sex and age groups’ time differences were assessed visually with boxplots 
and with Wilcoxon rank sum and Kruskal-Wallis nonparametric tests. Recall period for subject 
interviews was calculated as the number of days between the date of symptom onset and the date 
of subject interview. Recall period and differences in the time of symptom onset were 
graphically assessed using a scatterplot and Locally Weighted Scatterplot Smoother and 
analyzed with Spearman rank correlations (rs). Multivariable median regression modeling13 was 
used to assess the associations of sex, age groups, and length of recall period (after log-
transformation) with the time of symptom onset, adjusting for randomized group assignment and 
site. All analyses were performed in SAS v 9.3 (SAS Institute, Cary, North Carolina). A 2-sided 
P > .05 was considered statistically significant. 
 
TABLE 1 Demographics of the ACS Patient Sample (N = 251)a 
Patient Characteristic Mean ± SD or n (%) 
Age, y 66.8 ± 11.8 
≤65 y 107 (43) 
66-79 y 114 (45) 
≥80 y 30 (12) 
Sex  
Female 88 (35) 
Male 163 (65) 
Abbreviation: ACS, acute coronary syndrome. 
aFor patients with differences of 48 hours or less of time from symptom onset between medical 
record and interview. 
 
RESULTS 
 
The mean (SD) age at enrollment of the 251 patients at enrollment was 66.8 (11.8) years. About 
a third (35%) were women. Fifteen (6%) patients had missing dates for interviews, so their recall 
period could not be calculated. Of the 236 who had dates for interviews, the median number of 
days between the date of symptoms onset and the interview was 29.5 days (mean [SD], 83.9 
[129.4] days). Table 1 gives the characteristics of the patient sample. 
 
Of the 251 subjects with complete data, the median difference between the 2 data sources for the 
time of symptom onset was 45.0 minutes (mean [SD], 303.1 [530.3] minutes) (see Table 2). 
There was no significant difference in the time of symptom onset between men and women (P = 
.72) for the 2 sources. The median difference between the 2 data sources in the time of symptom 
onset by age groups was 40.0 minutes for 65 years or younger, 40.0 minutes for 66 to 79 years, 
and 132.5 minutes for 80 years or older, although these did not differ statistically (P = .188). 
 
TABLE 2 Recall Period and Time From Symptom Onset (N = 251)a 
Finding Median (Min, Max) or n (%) 
Recall period, d 29.5 (0, 986) 
Missing 15 (6) 
Difference in time of symptom onset between 
data sources, min 
45.0 (0, 2880) 
<30 min 91 (36) 
30-<60 min 38 (15) 
60-<90 min 17 (7) 
90 min to 48 h 105 (42) 
>48 h ˗ 
aFor patients with differences of 48 hours or less of time from symptom onset between medical 
record and interview. 
 
Greater differences in the time of symptom onset between the MR and the interview were 
associated with longer recall periods (see the Figure). Specifically, there was a significant 
correlation between differences in the time from symptom onset and recall (rs = 0.148, P = .023). 
Using multivariable median regression (see Table 3), there were no significant associations with 
differences between the 2 data sources in the time of symptom onset, except for log-transformed 
length of recall period (P = .023). Longer recall periods were significantly associated with 
greater differences in the time of symptom onset between the MR and interviews, adjusting for 
other model covariates (b = 13.2; 95% confidence interval, 1.9-24.6). For example, interviews 
conducted 3 days after the event were associated with an 18-minute difference; interviews done 7 
days afterward were associated with a 27-minute difference. If the recall period was greater than 
approximately 9 days, the difference between the 2 data sources exceeded 30 minutes. 
 
FIGURE IS OMITTED FROM THIS FORMATTED DOCUMENT 
Figure. Scatterplot of time of symptom onset differences for medical record (MR) relative to 
subject interview (SI) versus length of recall period from subject interview for the 251 ACS 
patients with time of symptom onset of 48 hours or less. 
TABLE 3 Multivariable Median Regression Analysis of Time of Symptom Onset in Minutes (n 
= 236)a 
Covariate B 95% CI for b P 
Sex    
Maleb -   
Female -10.46 -37.60 to 16.68 .4485 
Age group    
≤65 y -68.00 -154.68 to 18.69 .1236 
66-79 y -72.81 -167.22 to 21.60 .1300 
≥80 yb -   
Recall period in days 13.21 1.85 to 24.57 .0229 
Abbreviation: CI, confidence interval. 
aMedian regression additionally adjusting for intervention arm and study site. Recall period was 
calculated as ln(days + 1), where days was difference between date of symptom onset and 
interview. Fifteen patients had missing dates of interviews for recall period and were excluded. 
bReference category. 
 
DISCUSSION 
 
We found significant discrepancies between the MR and patient interview in time of symptom 
onset, but with no definitive indication of which was more accurate. Notably, a longer recall 
period was associated with a greater difference in the 2 sources of information. On the basis of 
these findings, nearly half (49%) of the patients in this study had more than a 1-hour difference 
between the 2 data sources. As determined in this study, a median difference of 45 minutes 
between the 2 data sources is clinically meaningful given that past studies have shown that for 
every 30 minutes of prehospital delay, there is a 7.5% increase in mortality.14 
 
We also found that in this study, the percentage of missing symptom onset data was much lower 
in the MR as compared with subject interviews done after the index event (3% vs 15%, 
respectively). In addition, this percentage of missing data in the MR in this study is markedly 
lower than that reported in previous studies (3% in the current study vs 14%-40%).3-7 It is 
possible that the ED clinicians were educated in advance of the PROMOTION study about the 
importance of documenting the time of symptom onset. However, the percentage of missing data 
from subject interviews in this study was about the same as reported in past studies (15% in 
current study vs 12%-13%).5,6 One explanation for a higher percentage of missing data from 
subject interviews is that the median length of time between the index event and the subject 
interview was about a month (29.5 days). Although the interviews were conducted by trained 
researchers, the length of time between the actual event and the interview probably influenced 
patients’ ability to remember the time of symptom onset. Thus, we recommend that data from 
subject interviews not be used to collect the time of symptom onset if the interviews are not 
conducted within 72 hours of the hospital admission. 
 
No differences by age or sex were noted related to discrepancies between the MR and the subject 
interview. One explanation for a lack of significant differences between the 2 data sources based 
on sex and age is that assessment techniques may have improved in patient groups that are more 
likely to have atypical symptoms (women and the elderly). 
STRENGTHS AND LIMITATIONS 
 
One strength of the study was that it is a multicenter international study that reported a low 
percentage of missing or incomplete data from the MR as compared with past studies in the 
literature. However, one limitation of this study is that the time of symptom onset from both data 
sources was from subject report provided retrospectively after the symptoms had occurred. Thus, 
no direct observations were done to determine the exact time of symptom onset in real time. 
 
IMPLICATIONS FOR CLINICAL PRACTICE 
 
Clinicians in acute and critical care settings face several challenges with obtaining an accurate 
time of symptom onset for patients presenting with suspected ACS and must do so within a time 
sensitive context. Clinicians are first charged with ensuring that symptoms of ischemia are 
assessed broadly, beyond chest pain as a single symptom, to avoid missing a potential ACS 
diagnosis. Second, clinicians may encounter patients who have difficulty articulating their 
symptom experience based on the questions asked. For example, some patients may have 
symptoms that evolve gradually, making it difficult for them to pinpoint the exact time of onset. 
Other patients may have difficulty quantifying vague or atypical symptoms. To overcome these 
challenges, there is need for a standardized evidence-based assessment procedure for patients 
with suspected ACS.15,16 Use of a standardized procedure would decrease the variability in 
clinical practice and provide evidence-based care for all patients with suspected ACS. For 
example, DeVon and colleagues17 have developed a 13-item ACS symptom checklist to be used 
for both clinical assessment and research. The instrument has established reliability and validity 
for use as a rapid triage assessment tool and is suitable for integration in an electronic health 
record (EHR).17 
 
Furthermore, incorporation of a standardized assessment procedure in the EHR has other 
potential advantages, such as improving completeness of documentation of symptoms, including 
the time of symptom onset. Clinicians in acute and critical care settings have an opportunity and 
an obligation to be champions in designing and using efficient assessment data collection 
processes. Input by clinicians can include which data elements should be entered as structured 
data (eg, quantifiable data such as systolic blood pressure or pain intensity level), discrete data in 
predefined categories (eg, presence or absence of certain ACS symptoms), or as textual data (eg, 
narrative data entered as free text).18 Clinicians can also provide input into clinical decision 
support tools, such as ‘‘Smart’’ computer Yassisted data entry options, which prompt clinicians 
to enter discrete data or double-check data entered (eg, the EHR can precalculate the time of 
symptom onset to hospital arrival). Options for rephrasing assessment questions could be used if 
a patient has difficulty answering a specific question related to symptoms. Furthermore, ‘‘real-
time’’ flags can be provided alerting the clinician that data are missing, thus providing an 
opportunity to increase completeness of assessment and documentation during the initial patient 
encounter.18 
 
CONCLUSION 
 
The findings from this study provide important information on assessing the time of cardiac 
symptom onset. The 2 data sources (MR vs subject interviews done after the acute event) are 
clearly not interchangeable, especially if the interviews are done more than 3 days after the index 
event. These findings indicate that documentation of symptom onset time in the MR has 
improved compared with previous studies. However, clinicians in acute and critical care settings 
should remain vigilant about accurate assessment and documentation of cardiac symptoms, 
especially in those patients with less discrete symptom onset. 
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